Nisa Investment Advisors, LLC Akero Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $24.1 Billion
- Q4 2024
A detailed history of Nisa Investment Advisors, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 960 shares of AKRO stock, worth $43,324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
960
Previous 786
22.14%
Holding current value
$43,324
Previous $22,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$333 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$310 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$272 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$252 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$236 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.09B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...